IFLR1000

Polyphor SIX Swiss Exchange IPO

16/5/2018
IPO
Select tab

SFr 165 million

Completed

16/5/2018

Overview:

  • Polypor listed its IPO on the Six Swiss Exchange.
  • The shares were priced at the upper end of the price range raising gross proceeds of $165 million (CHF 165 million)
  • The issuer is a clinical-stage bio-pharmaceutical company focused on the discovery and development of innovative antibiotics and other specialty pharma products.
  • It is the largest biotech IPO in Switzerland in over 10 years. 

Rajeeb Gurung - Researcher

Jurisdiction:

Switzerland

Deal type:

IPO

Practice area:

IPOs

Governing law:

Switzerland

Industry sector:

Pharmaceuticals and life sciences

Firms:
Bär & Karrer

Party: UBS (Joint global coordinating bookrunners )

Party: Deutsche Bank (Joint global coordinating bookrunners )

Party: Zurich Cantonal Bank (Co-Lead manager)

Party: Cantor Fitzgerald Securities (Co-Lead manager)

Lawyer: Christoph Suter

Linklaters

Party: UBS (Joint global coordinating bookrunners )

Party: Deutsche Bank (Joint global coordinating bookrunners)

Party: Zurich Cantonal Bank (Co-Lead manager)

Party: Cantor Fitzgerald Securities (Co-Lead manager)

Skadden Arps Slate Meagher & Flom

Party: Polyphor (Issuer)

VISCHER

Party: Polyphor (Issuer)

Related deals